CRNX Crinetics Pharmaceuticals, Inc.
8-K Current Report
Filed: February 26, 2026
Health Care
Pharmaceutical PreparationsCrinetics Pharmaceuticals, Inc. (CRNX) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Crinetics reported FY2025 financial results (period ended Dec 31, 2025) via press release on Feb 26, 2026
- • Full results in Exhibit 99.1 — key figures, revenue, and guidance details found there
Other Crinetics Pharmaceuticals, Inc. 8-K Filings
Get deeper insights on Crinetics Pharmaceuticals, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.